#93 - Simon Erickson - Personalised Medicine, Machine Learning Inference & Waymo's Self Driving Car
Today I’ve got Simon Erickson on the show. Simon is the founder and CEO of 7investing where they empower you to invest in your future! They provide subscribers with the "7 investment ideas" every month.
Before this Simon was also at Motley Fool for 7 years as the lead advisor of Motley Fool Explorer, investing each month into the market's most innovative companies.
Simon is a forward-looking investor, focused on identifying disruptive innovation and finding developing trends before others may even be aware of them. This focus has unlocked some unique experiences such as riding in the beta-version of Waymo’s self-driving car and taking a DNA test to explain how you’d react to prescription drugs.
In this interview, we discuss the 3 most exciting and disruptive themes for the next decade including personalised medicine, why an economic moat is so important, and when it’s right to sell a stock.
7investing has given the Opto team a special promo code for access to their subscription service. Use code "opto" at (7investing.com/subscribe) and you’ll get a $25 discount off your first month.
Thanks to Cofruition for consulting on and producing the podcast. Want further Opto insights? Check out our daily newsletter: https://www.cmcmarkets.com/en-gb/opto/newsletter
Past performance is not a reliable indicator of future results.
CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment, or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction, or investment strategy is suitable for any specific person.
The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination.
CMC Markets does not endorse or offer opinions on the trading strategies used by the author. Their trading strategies do not guarantee any return and CMC Markets shall not be held responsible for any loss that you may incur, either directly or indirectly, arising from any investment based on any information contained herein. for any loss that you may incur, either directly or indirectly, arising from any investment based on any information contained herein.